In a previous work, we showed that the angiotensin II type 1 receptor inhibitor losartan used to treat aortic aneurysm and prevent dissection in MFS (Brooke et al., 2008), improved microfibril deposition in MS fibroblasts (Piccolo et al., 2014). Here, AGTR1 is linked to aortic aneurysm.